Concepedia

Paul Jackson

PJ

Statistics

Publications

42

Citations

2.2K

H-Index

25

Active since

1985

Affiliations

Janssen (United States)(Current)

Johnson & Johnson (United States)

Guilford College

The University of Melbourne

Walter and Eliza Hall Institute of Medical Research

Paul Jackson is an author at Janssen (United States) specializing in pharmacology, medicinal chemistry, and neuropharmacology.

Publications per year

1985–2025

42

Publications

42

Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury

Barbara S. Slusher, James J. Vornov, Ajit G. Thomas et al. · Nature Medicine · 1999 · 302 citations

, , +13

Design, Synthesis, and Biological Activity of a Potent Inhibitor of the Neuropeptidase N-Acetylated α-Linked Acidic Dipeptidase

Paul Jackson, Derek C. Cole, Barbara S. Slusher et al. · Journal of Medicinal Chemistry · 1996 · 256 citations · Full text

, , +17

Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation

Robert H. Scannevin, Richard Alexander, Tara Mezzasalma Haarlander et al. · Journal of Biological Chemistry · 2017 · 175 citations · Full text

, , +12

Neuroprotective Effects of Inhibiting Poly(ADP-Ribose) Synthetase on Focal Cerebral Ischemia in Rats

Kazushi Takahashi, Joel Greenberg, Paul Jackson et al. · Journal of Cerebral Blood Flow & Metabolism · 1997 · 158 citations

, , +15

Regioselective Preparation of 2-Substituted 3,4-Diaryl Pyrroles:  A Concise Total Synthesis of Ningalin B

James L. Bullington, Russell R. Wolff, Paul Jackson · The Journal of Organic Chemistry · 2002 · 109 citations

, , +16

1–5 of 42